Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
暂无分享，去创建一个
L. Roisman | N. Peled | L. Nesher | K. Lavrenkov | W. Kian | D. Levitas | A. Yakobson | W. Shalata | K. Rouvinov | Ismaell Massalha | W. Alguayn | A. A. Sharb | M. Zemel | E. Levison | E. H. Kestenbaum | Anna Ievko | Regina Michlin | M. A. Abod | E. Chernomordikov | I. Massalha